WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹7,070 Cr | ₹7,075 Cr | ₹7,670 Cr | ₹7,376 Cr | ₹7,749 Cr |
What is the latest Total Liabilities ratio of WOCKHARDT ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹7,070 Cr |
Mar2023 | ₹7,075 Cr |
Mar2022 | ₹7,670 Cr |
Mar2021 | ₹7,376 Cr |
Mar2020 | ₹7,749 Cr |
How is Total Liabilities of WOCKHARDT Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹7,070 Cr | -0.07 | |
Mar2023 | ₹7,075 Cr | -7.76 | |
Mar2022 | ₹7,670 Cr | 3.99 | |
Mar2021 | ₹7,376 Cr | -4.82 | |
Mar2020 | ₹7,749 Cr | - |
Compare Total Liabilities of peers of WOCKHARDT
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WOCKHARDT | ₹17,193.1 Cr | 0.3% | 6% | 396.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹456,509.0 Cr | -1.9% | -0.6% | 64.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,240.0 Cr | -2.5% | 7.1% | 63.9% | Stock Analytics | |
CIPLA | ₹121,422.0 Cr | -2.2% | -9.4% | 26.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,505.0 Cr | -2.7% | -2.7% | 18.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,293.0 Cr | -1.5% | -6.9% | 76.2% | Stock Analytics |
WOCKHARDT Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WOCKHARDT | 0.3% |
6% |
396.2% |
SENSEX | -1.4% |
-6.1% |
23.9% |
You may also like the below Video Courses